HHS has ‘slammed on the brakes’ with ACA outreach

Groups which have previously partnered with HHS to promote open enrollment on the Affordable Care Act (ACA) exchanges say there have been no signs that work will continue in the first enrollment period under President Donald Trump.

The administration first made an impact towards the end of the last sign-up period, pulling advertisements for the federal Healthcare.gov marketplace just before the Jan. 31 deadline to purchase coverage, a time when many younger, healthier customers enrolled. That decision was later blamed for the lower-than-expected enrollment for 2017.

For the 2018 enrollment period, Talking Points Memo reports HHS has “abandoned” outreach and education work done by organizations since the ACA exchanges opened. This includes work done by groups not politically aligned with Republicans and the administration as well as non-partisan, religious and medical organizations.

“It feels like someone has slammed on the brakes and we’re all lurching forward,” said Amanda Hooper, the director of engagement and mobilization with the National Women’s Law Center. “It’s completely night and day—working with an administration that’s invested in the ACA and getting people covered and the Trump administration, which is actively working to take healthcare away from millions of people. It’s a stark, stark contrast.”

Read the full article at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.